Advancing aflatoxin analytical techniques: harnessing next-generation technologies and industrial innovations for precision quantification and qualitative profiling—a prospective approach toward public health safeguarding
Journal of Food Measurement & Characterization,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 11, 2025
Язык: Английский
A Review on Various Surface Plasmon Resonance-Based Sensors
Plasmonics,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 3, 2025
Язык: Английский
Magnetic Fe3O4@Au@PDA core-shell nanoparticle-enhanced SPR detection of tebuconazole
Microchemical Journal,
Год журнала:
2025,
Номер
unknown, С. 113472 - 113472
Опубликована: Март 1, 2025
Язык: Английский
Progress in Surface Plasmon and Other Resonance Biosensors for Biomedical Applications
Advanced Materials Technologies,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 17, 2025
Abstract
In
today's
technologically
advanced
era,
the
demand
for
swift
and
precise
analyses
spans
scientific
research
industrial
applications
alike.
Surface
plasmon
resonance
(SPR)
technology
has
surged
in
popularity,
due
to
its
real‐time
measurement
capabilities
with
exceptional
sensitivity
label‐free
operation.
These
attributes
have
propelled
SPR
into
prominence
across
diverse
fields
including
medical
diagnostics,
pharmaceuticals,
food
safety,
environmental
monitoring
of
hazardous
compounds.
Here
key
principles
behind
are
delved,
workings
SPR‐based
sensors
elucidated.
Additionally,
latest
advancements
biosensors
tailored
detecting
a
variety
analytes,
focus
on
dopamine
(DA)
α‐synuclein,
which
hold
particular
significance
context
neurological
disorders,
examined.
potential
breakthroughs
discussed,
thanks
integration
nanomaterials,
lab‐on‐a‐chip
devices,
multiplexing
formats,
machine
learning.
Finally,
new
modes
discussed
based
subwavelength
structures
leveraging
guided
mode
(GMR),
surface
lattice
(SLR),
bound
state
continuum
(BIC)
their
applications,
particularly
nonplasmonic
refractive
index
biosensors.
Язык: Английский
Numerical Investigation of a D‐Shaped Fiber‐Optic Biosensor Utilizing Surface Plasmon Resonance for Early Cancer Cell Detection
Опубликована: Авг. 7, 2024
The
field
of
biosensors
has
found
great
use
for
surface
plasmon
resonance
(SPR),
which
attracted
attention
its
multiple
applications.
With
the
goal
early
cancer
detection
at
level
a
single
living
cell,
this
research
numerically
investigates
very
sensitive
D-shaped
fiber-optic
biosensor
based
on
(SPR).
titanium
oxide
(TiO2)
is
coated
gold
(Au),
utilized
as
thin-film
plasmonic
material
in
suggested
structure.
guiding
light
fiber
modeled
using
finite
element
method
(FEM)
when
six
different
types
healthy
human
cells
and
their
malignant
counterparts
are
exposed
to
region.
Refractive
index
(RI)
differences
between
through
analysis
optical
spectra
amplitudes.
This
enables
us
identify
small
changes
characteristics
that
could
be
sign
pathogenic
alterations.
In
work,
we
concentrated
three
forms
cancer:
skin
(basal
cell)
breast
(MDA-MB-231
MCF-7).
results
show
parameters
optimal
ensure
sensor
performs
well
used
detect
under
study.
When
sensor’s
performance
compared
SPR
sensors
have
previously
been
published
literature,
it
becomes
clear
our
offers
promise
detection.
Язык: Английский
Analytical and bioanalytical chemistry for digital diagnostics in digital healthcare
Analytical and Bioanalytical Chemistry,
Год журнала:
2024,
Номер
unknown
Опубликована: Авг. 31, 2024
Язык: Английский
Exploring the Interaction of Biotinylated FcGamma RI and IgG1 Monoclonal Antibodies on Streptavidin-Coated Plasmonic Sensor Chips for Label-Free VEGF Detection
Biosensors,
Год журнала:
2024,
Номер
14(12), С. 634 - 634
Опубликована: Дек. 20, 2024
Vascular
endothelial
growth
factor
(VEGF)
is
a
critical
angiogenesis
biomarker
associated
with
various
pathological
conditions,
including
cancer.
This
study
leverages
pre-biotinylated
FcγRI
interactions
IgG1-type
monoclonal
antibodies
to
develop
sensitive
VEGF
detection
method.
Utilizing
surface
plasmon
resonance
(SPR)
technology,
we
characterized
the
binding
dynamics
of
immobilized
biotinylated
an
antibody,
Bevacizumab
(AVT),
through
kinetic
studies
and
investigated
suitable
conditions
for
sensor
regeneration.
Subsequently,
FcγRI-captured
AVT
VEGF,
calculating
constants
affinity.
A
calibration
curve
was
established
analyze
quantification
capacity
accuracy
biosensor,
computing
limits
blank,
detection,
at
95%
confidence
interval.
Additionally,
specificity
biosensor
over
other
protein
analytes
assessed.
innovative
biomimetic
approach
enabled
FcγRI-mediated
site-specific
capture,
establishing
stable
reusable
platform
detecting
accurately
quantifying
VEGF.
The
results
indicate
effectiveness
plasmonic
making
it
research
applications
and,
potentially,
clinical
diagnostics.
FcγRI-IgG1
antibody
binding,
this
highlights
industrial
value
advanced
biosensing
technologies,
offering
insights
enhance
therapeutic
monitoring
improve
outcomes
in
anti-VEGF
therapies.
Язык: Английский